Collection 專利 [0/7] 期刊論文 [33/34] Siblings 劉淦光(2006-2014) [23/23] 劉鴻興 [9/9] 喻秋華 [60/60] 孫以瀚 [1/1] 張仲明 [30/31] 張明姿 [17/17] 張雅媗 [10/10] 徐唯哲 [8/8] 徐欣伶 [20/23] 施修明 [35/39] 松浦功 [21/26] 梁啟銘(2006-2007) [4/4] 江運金 [34/34] 王紹文 [15/15] 王陸海 [36/37] 莊志立 [32/38] 蔡世峯 [134/147] 許惠恒 [40/40] 陳俊宏 [16/16] 黃秀芬 [130/140] 黃麗蓉 [26/28] 龔行健 [61/63] 其他 [157/163] 周玉山(1996-2005) [20/22] 王玲美(2004-2008) [4/4] 葉秀慧(2001-2005) [21/22] 鄭金松(1997-2002) [6/6] 黃奇英(1998-2005) [32/34] Community Statistics 近3年內發表的文件:2(4.88%) 含全文筆數:33(80.49%) 文件下載次數統計 下載大於0次:33(100.00%) 下載大於100次:32(96.97%) 檔案下載總次數:27665(0.47%) 最後更新時間: 2025-04-28 20:32 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 MetS-Z: A gender- and age-specific ... 티로신 키나아제 억제제로서의 접합 이환 및 삼환 피리미딘 화합물 作為酪胺酸激酶抑制劑的稠合雙環及多環嘧啶化合物 チロシンキナーゼ阻害剤としての融合2環および3環ピリミジン化合物 作爲酪胺酸激酶抑制劑的稠合雙環及多環嘧啶化合物 DUSP22 inhibits lung tumorigenesis ... CA10 is associated with HBV-related... DUSP3 regulates phosphorylation-med... EGFR mutation-harboring lung cancer... Dysregulated Kras/YY1/ZNF322A/Shh t...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-41 / 41. (共1頁) 1  每頁顯示[10|25|50]項目

日期	題名	關聯
2025-02-13	MetS-Z: A gender- and age-specific scoring system for predicting type 2 diabetes	Journal of Diabetes Investigation. 2025 Feb 13;Article in Press.
2024-06-14	DUSP22 inhibits lung tumorigenesis by suppression of EGFR/c-Met signaling	Cell Death Discovery. 2024 Jun 14;10:Article number 285.
2022-09	CA10 is associated with HBV-related hepatocarcinogenesis	Biochemistry and Biophysics Reports. 2022 Sep;31:Article number 101303.
2022-06-15	DUSP3 regulates phosphorylation-mediated degradation of occludin and is required for maintaining epithelial tight junction	Journal of Biomedical Science. 2022 Jun 15;29:Article number 40.
2022-03-04	EGFR mutation-harboring lung cancer cells produce CLEC11A with endothelial trophic and tumor-promoting activities	Cancers. 2022 Mar 4;14(5):Article number 1356.
2020-08-08	Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression	Theranostics. 2020 Aug 8;10(22):10001-10015.
2019-10	MAP4K3/GLK promotes lung cancer metastasis by phosphorylating and activating IQGAP1	Cancer Research. 2019 Oct;79(19):4978-4993.
2017-11	Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration	Oncogene. 2017 Nov;36(47):6509-6517.
2017-07-12	NEAP/DUSP26 suppresses receptor tyrosine kinases and regulates neuronal development in zebrafish	Scientific Reports. 2017 Jul 12;7:Article number 5241.
2017-02-01	티로신 키나아제 억제제로서의 접합 이환 및 삼환 피리미딘 화합물	KR10-1703941/2017-02-01
2016-07	Changes of serum amino acid profiles by an epidermal growth factor receptor mutation and benzo[a]pyrene in mouse lung tumorigenesis	Toxicology Research. 2016 Jul;5(4):1182-1192.
2016-02-19	作為酪胺酸激酶抑制劑的稠合雙環及多環嘧啶化合物	HK1162509/2016-02-19
2016-02-04	作爲酪胺酸激酶抑制劑的稠合雙環及多環嘧啶化合物	J/001914/2016-02-04
2015-07-24	チロシンキナーゼ阻害剤としての融合2環および3環ピリミジン化合物	JP5781934/2015-07-24
2015-07-22	作为酪胺酸激酶抑制剂的稠合双环及多环嘧啶化合物	CN102264745/2015-07-22
2015-07	EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82	Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2015 Jul;1852(7):1540-1549.
2015-04-18	Akt suppresses DLK for maintaining self-renewal of mouse embryonic stem cells	Cell Cycle. 2015 Apr 18;14(8):1207-1217.
2013-08-13	Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors	US8507502/2013-08-13
2013-08	Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan	PLoS ONE. 2013 Aug;8(8):Article number e70839.
2013-03-08	Protein phosphorylation profiling using an in situ proximity ligation assay: Phosphorylation of AURKA-Elicited EGFR-Thr654 and EGFR-Ser1046 in lung cancer cells	PLoS ONE. 2013 Mar 8;8(3):Article number e55657.
2013-02-11	作為酪胺酸激酶抑制劑之稠合雙環及多環嘧啶化合物	TWI385174/2013-02-11
2012-07	Correlation of anaplastic lymphoma kinase overexpression and the EML4-ALK fusion gene in non-small cell lung cancer by immunohistochemical study	Chang Gung Medical Journal. 2012 Jul;35(4):309-317.
2012-02	UTF1 deficiency promotes retinoic acid-induced neuronal differentiation in P19 embryonal carcinoma cells	International Journal of Biochemistry and Cell Biology. 2012 Feb;44(2):350-357.
2012-01	A High-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors	Anticancer Research. 2012 Jan;32(1):147-151.
2011-12	Clinical implications of high MET gene dosage in non-small cell lung cancer patients without previous tyrosine kinase inhibitor treatment	Journal of Thoracic Oncology. 2011 Dec;6(12):2027-2035.
2011-03	Vaccinia H1-related phosphatase is a phosphatase of ErbB receptors and is down-regulated in non-small cell lung cancer	Journal of Biological Chemistry. 2011 Mar;286(12):10177-10184.
2010-10-28	Design and synthesis of tetrahydropyridothieno[2,3-d]pyrimidine scaffold based epidermal growth factor receptor (EGFR) kinase inhibitors: the role of side chain chirality and michael acceptor group for maximal potency	Journal of Medicinal Chemistry. 2010 Oct 28;53(20):7316-7326.
2010-09	The dimeric transmembrane domain of prolyl dipeptidase DPP-IV contributes to its quaternary structure and enzymatic activities	Protein Science. 2010 Sep;19(9):1627-1638.
2010-08	Prognostic implications of epidermal growth factor receptor and KRAS gene mutations and epidermal growth factor receptor gene copy numbers in patients with surgically resectable non-small cell lung cancer in Taiwan	Journal of Thoracic Oncology. 2010 Aug;5(8):1175-1184.
2010-06	Chimeric mouse models for lung adenocarcinomas	Future Oncology. 2010 Jun;6(6):901-903.
2010-02	JNK pathway-associated phosphatase dephosphorylates focal adhesion kinase and suppresses cell migration	Journal of Biological Chemistry. 2010 Feb;285(8):5472-5478.
2008-12	NEAP causes down-regulation of EGFR, subsequently induces the suppression of NGF-induced differentiation in PC12 cells	Journal of Neurochemistry. 2008 Dec;107(6):1544-1555.
2008-10-17	Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications	Cancer. 2008 Oct 17;113(11):3199-3208.
2008-09	Increased epidermal growth factor receptor (EGFR) gene copy number is strongly associated with EGFR mutations and adenocarcinoma in non-small cell lung cancers: A chromogenic in situ hybridization study of 182 patients	Lung Cancer. 2008 Sep;61(3):328-339.
2008-06-01	A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors	Analytical Biochemistry. 2008 Jun;377(1):89-94.
2008-02-07	EGFR mutants found in non-small cell lung cancer show different levels of sensitivity to suppression of Src: implications in targeting therapy	Oncogene. 2008 Feb;27(7):957-965.
2007-09-01	MCT-1 oncogene downregulates p53 and destabilizes genome structure in the response to DNA double-strand damage	DNA Repair. 2007 Sep;6(9):1319-1332.
2007-06-01	Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis	International Journal of Cancer. 2007 Jun;120(11):2377-2385.
2006-07	Biochemical and biological characterization of a neuroendocrine-associated phosphatase	Journal of Neurochemistry. 2006 Jul;98(1):89-101.
2006-02-23	Distinctive activation patterns in constitutively active and gefitinib-sensitive EGFR mutants	Oncogene. 2006 Feb;25(8):1205-1215.
2004-12-15	High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan	Clinical Cancer Research. 2004 Dec;10(24):8195-8203.

顯示項目1-41 / 41. (共1頁) 1  每頁顯示[10|25|50]項目